| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.4 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |